Off-market insider buying at Marvel Biosciences (MRVL)
Joseph Roderick Matheson, a Senior Officer, Director and 10% Holder, acquired 857,142 Common Shares on a direct ownership basis at a price of $0.140 through a private transaction on February 24th, 2026. This represents a $120,000 investment into the company's shares and an account share holdings change of 13.8%.
Let the insiders guide you to opportunity at Canadianinsider.com.
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.